BMJ Open (Mar 2022)
Which outcomes should be used in future bronchiolitis trials? Developing a bronchiolitis core outcome set using a systematic review, Delphi survey and a consensus workshop
- Matthew Peak,
- Ricardo M Fernandes,
- Kerry Woolfall,
- David Lacy,
- Emma Bedson,
- Mark David Lyttle,
- Paula R Williamson,
- Paul S McNamara,
- Ashley P Jones,
- Vanessa Compton,
- Clare van Miert,
- Kentigern Thorburn,
- A Rosala-Hallas
Affiliations
- Matthew Peak
- Paediatric Medicines Research Unit, Alder Hey Children`s NHS Foundation Trust, Liverpool, UK
- Ricardo M Fernandes
- 3 Instituto de Medicina Molecular, Clinical Pharmacology and Therapeutics, Faculty of Medicine, Universidade de Lisboa, Lisbon, Portugal
- Kerry Woolfall
- Institute of Population Health, Department of Public Health, Policy and Systems, University of Liverpool, Liverpool, UK
- David Lacy
- 5 Department of Paediatrics, Wirral University Teaching Hospital NHS Foundation Trust, Wirral, UK
- Emma Bedson
- 1 Liverpool Clinical Trials Centre, Department of Biostatistics, University of Liverpool (a member of Liverpool Health Partners), Liverpool, UK
- Mark David Lyttle
- Emergency Department, Bristol Royal Hospital for Children, Bristol, UK
- Paula R Williamson
- director, professor
- Paul S McNamara
- 11 Institute of Child Health, University of Liverpool, Liverpool, Merseyside, UK
- Ashley P Jones
- Liverpool Clinical Trial Centre, University of Liverpool, Liverpool, UK
- Vanessa Compton
- 2 Paediatric Intensive Care Unit, Alder Hey Children’s NHS Foundation Trust, Liverpool, Merseyside, UK
- Clare van Miert
- 2 Paediatric Intensive Care Unit, Alder Hey Children’s NHS Foundation Trust, Liverpool, Merseyside, UK
- Kentigern Thorburn
- Paediatric Intensive Care Unit, Alder Hey Children`s Hospital, Liverpool, UK
- A Rosala-Hallas
- Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, Merseyside, UK
- DOI
- https://doi.org/10.1136/bmjopen-2021-052943
- Journal volume & issue
-
Vol. 12,
no. 3
Abstract
No abstracts available.